NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton’s report has stated that the pharmaceutical continuous manufacturing market in North America is evaluated to advance at a CAGR of 10.07% during the predicted years 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries studied in this market are:

•        United States

•        Canada

In North America, the studied market is estimated to grow at a steady pace due to the well-developed pharmaceutical industry and growth in the use of continuous manufacturing systems. Additionally, the higher adoption of advanced technologies, innovative continuous manufacturing systems, and trained professionals to operate complex manufacturing equipment are another set of factors expected to motivate the pharmaceutical continuous manufacturing market’s growth across North America.

In the United States, pharmaceutical companies are considered to conduct half of global research and development activities, with numerous companies holding the intellectual property rights on several novel drugs. Further, multiple government initiatives to support the utilization of continuous manufacturing technologies are motivating the studied market’s progress to a large extent. For instance, the US FDA is motivating pharma companies to adopt continuous manufacturing methods, while providing faster approval processes. These factors significantly drive the progression of the pharmaceutical continuous manufacturing market in the United States.

Furthermore, significant market players, such as Thermofisher and Munson Machinery, are also supporting the studied market’s development. Moreover, due to the COVID-19 outbreak, the country is likely to shift its manufacturing units from China to other parts of Asia, which will reduce its dependency on the Chinese market for pharmaceutical products. These factors are also likely to augment the pharmaceutical continuous manufacturing market’s growth across the United States.

Munson Machinery Company is a private and non-profit company providing processing machinery to its clients. Moreover, it is regularly involved in the development of equipment performance to compete with other manufacturers. Its product portfolio includes a rotary continuous mixer that assists in reducing labor and operational cost significantly when mixing dry mass of solids, with or without liquid supplements. The company was founded in 1823, with its headquarter based in the United States.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   RISE IN INITIATIVES TAKEN BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.7.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.7.3.   RISING HEALTHCARE EXPENDITURE

2.8. MARKET RESTRAINTS

2.8.1.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.9. MARKET OPPORTUNITIES

2.9.1.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - NORTH AMERICA

6.1. COUNTRY ANALYSIS

6.1.1.   UNITED STATES

6.1.2.   CANADA

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMOFISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 3:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 5:       NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     NORTH AMERICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 11:  CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;